{"id":"https://openalex.org/W4361909486","doi":"https://doi.org/10.1158/1078-0432.22454720.v1","title":"Supplementary Figures from HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma","display_name":"Supplementary Figures from HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361909486","doi":"https://doi.org/10.1158/1078-0432.22454720.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22454720.v1","doi":"https://doi.org/10.1158/1078-0432.22454720.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454720.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39905837","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/ndownloader/files/39905837","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100680442","display_name":"Hong Yu Zheng","orcid":"https://orcid.org/0000-0001-5802-330X","observed_orcids":["https://orcid.org/0000-0001-5802-330X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Zheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112124761","display_name":"Weipeng Zhao","orcid":"https://orcid.org/0000-0002-7909-9490","observed_orcids":["https://orcid.org/0000-0002-7909-9490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weipeng Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100864417","display_name":"Cihui Yan","orcid":"https://orcid.org/0000-0002-9391-0403","observed_orcids":["https://orcid.org/0000-0002-9391-0403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cihui Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091743959","display_name":"Crystina C. Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Crystina C. Watson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025351008","display_name":"Michael T. Massengill","orcid":"https://orcid.org/0000-0003-0408-6596","observed_orcids":["https://orcid.org/0000-0003-0408-6596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Massengill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101108480","display_name":"Mengyu Xie","orcid":"https://orcid.org/0009-0009-3653-6636","observed_orcids":["https://orcid.org/0009-0009-3653-6636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mengyu Xie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059727935","display_name":"Chris Massengill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Massengill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111712584","display_name":"David R. Noyes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R. Noyes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007221296","display_name":"Gary V. Martinez","orcid":"https://orcid.org/0000-0002-6204-8363","observed_orcids":["https://orcid.org/0000-0002-6204-8363"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary V. Martinez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028266454","display_name":"Roha Afzal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roha Afzal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100709550","display_name":"Zhihua Chen","orcid":"https://orcid.org/0000-0002-4390-7636","observed_orcids":["https://orcid.org/0000-0002-4390-7636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhihua Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100606004","display_name":"Xiubao Ren","orcid":"https://orcid.org/0000-0003-4137-2049","observed_orcids":["https://orcid.org/0000-0003-4137-2049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiubao Ren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott J. Antonia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064494204","display_name":"Eric B. Haura","orcid":"https://orcid.org/0000-0003-3114-1909","observed_orcids":["https://orcid.org/0000-0003-3114-1909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric B. Haura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021009961","display_name":"Brian Ruffell","orcid":"https://orcid.org/0000-0002-3846-6872","observed_orcids":["https://orcid.org/0000-0002-3846-6872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Ruffell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032171890","display_name":"Amer A. Beg","orcid":"https://orcid.org/0000-0003-3834-774X","observed_orcids":["https://orcid.org/0000-0003-3834-774X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amer A. Beg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0406000018119812,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.902999997138977},{"id":"https://openalex.org/keywords/romidepsin","display_name":"romidepsin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":0.8759999871253967},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":1.0},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6639999747276306},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7580000162124634},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.5389999747276306},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5450000166893005},{"id":"https://openalex.org/keywords/mouse-tumor-model","display_name":"mouse tumor model","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.9068619012832642},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5820873975753784},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4099269509315491},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38239526748657227},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37846627831459045},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36617332696914673},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35122284293174744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3308420777320862},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26756399869918823},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09885454177856445},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22454720.v1","doi":"https://doi.org/10.1158/1078-0432.22454720.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454720.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39905837","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22454720","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_from_HDAC_Inhibitors_Enhance_T-Cell_Chemokine_Expression_and_Augment_Response_to_PD-1_Immunotherapy_in_Lung_Adenocarcinoma/22454720","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22454720.v1","doi":"https://doi.org/10.1158/1078-0432.22454720.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454720.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39905837","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361909486.pdf","grobid_xml":"https://content.openalex.org/works/W4361909486.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2296591944","https://openalex.org/W4361958792","https://openalex.org/W2977401980","https://openalex.org/W3039544508","https://openalex.org/W2021418277","https://openalex.org/W2944327888","https://openalex.org/W2919752764","https://openalex.org/W2999334094","https://openalex.org/W4313399632","https://openalex.org/W2947987820"],"abstract_inverted_index":{"Fig.":[0,12,40,51,74,108,126,159,187,236,265,298],"S1.":[1],"Screening":[2],"of":[3,15,44,54,63,81,112,168,171,248,291,303],"oncology":[4],"drugs":[5],"to":[6,22,33,222],"identify":[7],"agents":[8],"with":[9,98,133,142,148,192,201,243,272,307],"immuno-stimulatory":[10],"properties.":[11],"S2.":[13],"Expression":[14],"Ccl5,":[16],"Cxcl9":[17],"and":[18,26,49,91,115,206,208,214,226,323],"Cxcl10":[19],"was":[20,220],"normalized":[21],"ribosomal":[23],"18s":[24],"RNA":[25],"is":[27,263],"shown":[28,318],"as":[29,72,103,157,313,328],"fold":[30],"change":[31],"compared":[32],"DMSO":[34],"treated":[35,141,200,306],"LKR":[36,120,172,245,304],"(set":[37],"at":[38,70],"1).":[39],"S3.":[41],"Treatment":[42],"regimen":[43],"mice":[45,64,129,191,239,268,292],"receiving":[46,65],"i.p.":[47,270],"anti-CD4/CD8":[48],"romidepsin.":[50],"S4.":[52],"Percentage":[53],"CD4":[55,224],"or":[56,68,101,149,199,311],"CD8":[57,67,227],"in":[58,86,230,319],"DAPI-":[59],"(viable)":[60],"peripheral":[61],"blood":[62,290],"anti-":[66],"anti-CD4":[69],"300mug,":[71],"indicated.":[73,104,158,314],"S5.":[75],"PD-L1":[76,82],"expression.":[77],"Cell":[78],"surface":[79],"expression":[80],"determined":[83],"by":[84,296],"FACS":[85,219],"viable":[87,232],"LKR,":[88],"393P":[89],"(393)":[90],"344SQ":[92,135],"(344)":[93,136],"cells":[94,173,233,282,305],"after":[95,174,182,217,277],"24h":[96],"treatment":[97,118,178,251],"30nM":[99],"romidepsin":[100,113,144,177,202,249,274],"IFNgamma":[102,175,312],"UT:":[105],"untreated":[106,197],"cells.":[107,246],"S6.":[109],"(A)":[110,161,189],"Impact":[111],"(n=6)":[114],"anti-PD-1":[116,152,209],"(n=7)":[117],"on":[119,145,154,203,211,253,256],"tumor":[121,257],"growth":[122,258],"for":[123,179],"47":[124],"days.":[125],"S7.":[127],"129":[128,190,238,267],"were":[130,140,196,240,269,294],"inoculated":[131,241],"s.c.":[132,242],"106":[134,244],"following":[137],"which":[138,218],"they":[139],"2mg/kg":[143,273],"days":[146,155,204,212,254],"14,16,18,":[147],"without":[150],"300\u03bcg/mouse":[151],"antibody":[153,210],"15,17,19":[156],"S8.":[160],"Heatmap":[162],"analysis":[163,302],"using":[164],"conventional":[165],"red-green":[166],"scale":[167],"microarray":[169],"results":[170],"and/or":[176],"genes":[180],"increased":[181],"combined":[183],"vs.":[184],"single":[185],"treatments.":[186],"S9.":[188],"day":[193],"14":[194,205],"tumors":[195],"(UT)":[198],"16":[207],"15":[213],"17":[215],"(RP)":[216],"used":[221],"determine":[223],"(CD3+CD4+)":[225],"(CD3+CD8+)":[228],"percentages":[229],"total":[231],"(day":[234],"19).":[235],"S10.":[237],"Effect":[247],"(Rom)":[250,309],"(2mg/kg":[252],"14,16,18)":[255],"over":[259],"indicated":[260,327],"time":[261],"periods":[262],"shown.":[264],"S11.":[266],"injected":[271],"twice.":[275],"48h":[276],"the":[278],"last":[279],"injection,":[280],"MDSC":[281],"(CD11b+":[283],"Gr1":[284],"+":[285],"Ly-":[286],"6G":[287],"+)":[288],"from":[289],"(n=3)":[293],"analyzed":[295],"FACS.":[297],"S12.":[299],"Western":[300],"blot":[301],"Romidepsin":[308],"and/":[310],"STAT1":[315],"levels":[316,325],"are":[317,326],"whole":[320],"cell":[321],"lysates":[322],"\u03b2-actin":[324],"controls":[329]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2023-04-05T00:00:00"}